Strong results from Quality Payments scheme says NHS England

Recent NHS England figures show that a majority of community pharmacies in England are offering improved care for patients with asthma and dementia since the introduction of the Quality Payments scheme.

NHS England’s uptake figures show that 97 per cent of pharmacies (11,410) are now signed up to the scheme. They also reveal that since April 2017 more than 12,500 asthma patients at high risk of suffering a severe asthma attack have been identified and referred for a full asthma review, and that 70,000 pharmacy staff have signed up to become Dementia Friends. 

Some other significant achievements under the scheme include almost 10,000 pharmacies becoming accredited healthy living pharmacies and more than 95 per cent of pharmacies accessing electronic patient summary care records to help them carry out their care duties with patients.

Deputy chief pharmaceutical officer Bruce Warner said: “We want pharmacists to make the most of their valuable clinical skills, helping patients to stay well all year round. It is fantastic to see the near universal uptake of the quality payments scheme leading to a range of benefits to patients, pharmacists and the wider NHS system. I welcome the response from community pharmacy in embracing these new ways of working.”

Professor Mike Morgan, NHS England’s national clinical director for respiratory services, said: “Frontline community pharmacists are in an excellent position to give potentially life-saving advice and it’s great to see that this scheme has delivered this significant step forward in patient care.”

Latest discussions

  1. Are pharmacists guinea pigs for covid19

    So, still the doctors are working from b...

  2. Are pharmacists guinea pigs for covid19

    VIVA LA PDAU,  VIVA LA CAC After the la...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.